Physician profile
Jonathan Redwing
NPI 1649309410
$694.93
in general payments reported to CMS, 2019-2025
9 companies · $74.83 in 2025
The $74.83 reported for 2025 was less than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $203 · 2022: $39.68 · 2023: $135 · 2024: $242 · 2025: $74.83.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $453.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $452.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $163.74 | 2021 | |
| Bioventus LLC | $158.96 | 2023-2025 | Durolane, Durolane, Xcell |
| Innovation Technologies INC | $147.12 | 2024 | Irrisept |
| Ferring Pharmaceuticals INC. | $83.70 | 2021-2023 | Euflexxa |
| Pylant Medical | $42.58 | 2024 | |
| Depuy Synthes Sales INC. | $35.89 | 2022-2025 | Monovisc, Orthovisc |
| Kci USA, INC. | $27.53 | 2023 | Prevena |
| Sanofi-Aventis U.S. LLC | $20.00 | 2021 | |
| Solventum Corporation | $15.41 | 2024 | V.A.C. Veraflo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Redwing listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.